PVP Ventures Ltd confirmed the payment of interest on its Non-Convertible Debentures (NCDs) on October 3, 2026. The payout, totaling ₹1.04 crore, was made three days after the scheduled due date of September 30, 2026.

The company attributed the delay to a "technical issue" in its intimation to stock exchanges. The payment covers two separate debt instruments with an aggregate issue size of ₹150 crore. The record date for this interest cycle was September 23, 2026.

Payment details and instrument specifics

The interest was disbursed to debenture holders listed as beneficial owners on the record date. The total amount paid comprises ₹65.68 lakh for one series and ₹38.02 lakh for another. Both instruments carry a quarterly interest frequency.

Regulatory compliance and context

This disclosure was made under Regulation 57 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The filing confirms that no change in the frequency of interest payments occurred during this period. The previous interest payment was made on July 21, 2026.

What the numbers show

The combined interest outflow of ₹1.04 crore against a total principal exposure of ₹150 crore implies an annualized yield of approximately 2.77% if viewed in isolation, though quarterly compounding or specific coupon structures may vary. The consistent quarterly payment schedule indicates regular debt servicing obligations, with the current delay being attributed to operational rather than liquidity constraints.

PVP Ventures has accepted the resignation of Dr. Ellen Jane Feehan as Executive Director and Chief Executive Officer, and Dr. Neeraja Nagarajan as Executive Director and Chief Operating Officer. Both departures are effective September 24, 2026.

Leadership change at PVP Ventures

The simultaneous exit of the top two executive officers marks a significant leadership development for the company. Dr. Ellen Jane Feehan tendered her resignation citing unavoidable personal health reasons. In her communication, she stated she was unable to take up the assignment offered under an Executive Employment Agreement dated July 1, 2026, and would not join on October 1, 2026.

Dr. Neeraja Nagarajan resigned due to the non-alignment of Dr. Ellen Feehan as CEO, with whom she was expected to synergize. Her resignation letter cited differentials in leadership styles, cultures, and operating models, alongside domicile requirements related to family in the United States.

Regulatory disclosures

The company informed stock exchanges under Regulation 30 read with Clause 7(C) of Para A of Part A of Schedule III of SEBI (LODR) Regulations, 2015. Prasad V. Potluri, Chairman and Managing Director of PVP Ventures, signed the official communication to the National Stock Exchange of India Limited and BSE Limited.

The filing noted that detailed communications from both directors were enclosed as annexures to the disclosure. The company's registered office is located in Chennai, with corporate offices in Hyderabad.